Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04597554 · ClinicalTrials.gov registry record · NA
Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT04597554 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 84 participants.
The verdict
NCT04597554, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study will investigate the effect of 8-weeks cranberry supplementation on the antibody response to influenza vaccination and ex-vivo anti-viral activity. The hypothesis is that 8-weeks ingestion of cranberry supplement relative to placebo will improve the antibody response to influenza vaccination and ex-vivo anti-viral defense.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Cranberry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04597554
The ClinicalTrials.gov registry entry for NCT04597554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04597554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04597554 about?
NCT04597554 is a clinical study titled "Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot". This study will investigate the effect of 8-weeks cranberry supplementation on the antibody response to influenza vaccination and ex-vivo anti-viral activity. The hypothesis is that 8-weeks ingestion of cranberry supplement relative to placebo will improve the antibody response to influenza vaccinat...
What is the current status of trial NCT04597554?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2020-09-21. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04597554?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Cranberry (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04597554?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.